TrialThe Journal of investigative dermatology2020

A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial).

Joel M Gelfand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.